Markets Earnings Screener Watchlist

Fundamentals and filings are sourced from SEC EDGAR. Market data, ownership and analyst consensus are sourced from Nasdaq. Written analysis is generated by metir from those sources and the linked reporting.

All information is provided for informational purposes only. It is not investment, financial, tax or legal advice, is not a recommendation to buy or sell any security, and is not intended for trading purposes. Data may be delayed or incomplete.

Markets open

Illumina, Inc. Stock Price: Quote, Financials, Forecast & News (ILMN)

Illumina, Inc.

ILMN · Nasdaq

Overview Financials Earnings Holders Historical Data Analysis

$201.00-$2.010.99%

As of: Aug 5, 2:40 PM

Prev Close: $203.01
Market Cap: $30.35B
Open: —
Trailing P/E: —
Day Range: $203.50 - $198.92
52W Range: $207.00 - $88.00
Forward P/E: —
EPS: —
Volume: 302.01K
Dividend Yield: —

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

Illumina, Inc. (ILMN) Hits Fresh High: Is There Still Room to Run?

Zacks · 2d ago

Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?

The Motley Fool · 4d ago

Illumina Q2 Earnings Call Highlights

MarketBeat · 5d ago

Illumina (ILMN) Q2 2026 Earnings Call Transcript

The Motley Fool · 6d ago

Illumina (ILMN) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks · 6d ago Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates

Zacks · 6d ago Illumina Inc. Profit Retreats In Q2

RTTNews · 6d ago Illumina Q2 26 Earnings Conference Call At 4:30 PM ET

RTTNews · 6d ago

Symbol: ILMN
Type: Stock
Sector: Health Care
Industry: Medical Specialities
Country: North America
Exchange: Nasdaq

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

Analyst Consensus

Hold

22 analysts

$201

Current

—

Low

$208

Average

—

High

Average target implies +3.48% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Centene CorporationCNC · NYSE$66.47

3.74%

Natera, Inc.NTRA · Nasdaq$277.931.00%

Humana Inc.HUM · NYSE$361.990.05%

The Cigna GroupCI · NYSE$270.511.29%

Beta

—

Avg Volume

1.98M